A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team has reported. In the first study of the drug lorcaserin in the human brain, the research revealed the mechanism underlying the drug’s efficacy and provides insight into which individuals may benefit most from the medication.